A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
Clinical trials in Dalton, GA: what is studied
Cancer. Cancer studies in Dalton run mainly through Tennessee Oncology's Dalton office and the Peeples Cancer Institute at Hamilton Medical Center, and often cover cancers such as lung cancer and kidney cancer; see our oncology clinical trials page.
Kidney, liver, and metabolic conditions. Local practices and research sites also take part in studies for chronic kidney disease, fatty liver disease, obesity, and type 2 diabetes. Our guide explains what works for fatty liver, and our weight loss clinical trials page lists studies of new weight loss medicines.
Paid clinical trials in Dalton
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything. Any payment has to be approved by the institutional review board that oversees the study, and FDA guidance says it should accrue as the study goes on rather than depend on finishing it. Many studies at least cover travel, which can make a study in Chattanooga or Atlanta more practical. Our guide explains how much clinical trials pay and how payment is decided.
Clinical trials near Dalton: Chattanooga and Atlanta
Dalton has a small number of studies of its own, but Chattanooga, about 30 miles away, has many more, and Atlanta is about 90 miles south. This page lists studies in Georgia, so studies across the state line appear on our Chattanooga page instead. Studies across the state are on our Georgia clinical trials page.
Can I join a clinical trial in Chattanooga if I live in Dalton?
Usually yes. Most studies accept anyone who meets the criteria and can attend the visits, wherever they live, so the main question is how often you would need to make the trip. The study coordinator can tell you the visit schedule and whether travel costs are covered.
How to join a clinical trial in Dalton
- Identify your trial. Use the filters on this page to narrow the list by condition or phase, or search a diagnosis such as fatty liver disease or lung cancer.
- Check the location. Each study lists the sites where it recruits, so confirm it has a site in Dalton, or decide whether a site in Chattanooga or Atlanta would work for you.
- Explore study details. Read the eligibility criteria and, where listed, the number of visits and how long the study lasts before applying.
- Complete the health profile. Click "See if you qualify" to begin the 5-step application. Have ready your diagnosis and when it was made, the medicines you take, and any recent test results.
- Submit the application. A clinical trial coordinator reviews it and contacts you to discuss next steps. Nothing is decided until informed consent, and participation is voluntary at every step.
Our guide to finding clinical trials near you covers each step in more detail.
Do I need health insurance to join a clinical trial?
Not necessarily. Study related care, including the study medicine and the visits and tests the protocol requires, is typically provided at no cost to participants, and the team explains anything that would be billed to insurance before you agree.
Our guide Are Clinical Trials Free? explains costs, insurance, and compensation.